mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

The company employs machine learning to uncover disease mechanisms at the mRNA level and to identify therapeutic candidates.

MRNA Vaccines: "The University of Sheffield's versatile RNAbox builds on the 'vaccine revolution' experienced during the ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

A large team of microbiologists, pathologists and infectious diseases specialists affiliated with several institutions in the ...

Messenger RNA (mRNA) serves as a blueprint for proteins. When mRNA is no longer needed, it must be degraded. Director Elena ...

THE Nobel Prize in Physiology-Medicine has been awarded to two scientists for their discovery of micro-RNA (mRNA), which ...

This growth has continued into 2024, with the rising value of licensing agreements reflecting growing confidence in this technology beyond application in vaccines. Global sales for innovator mRNA ...

In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.